STECHER GUZMAN, XIMENA PATRICIA
Preferred name
STECHER GUZMAN, XIMENA PATRICIA
Main Affiliation
Email
xstecher@udd.cl
ORCID
0000-0002-7962-9519
Scopus Author ID
56394442700
27 results
Now showing 1 - 10 of 27
- Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Coupling between neural oscillations and white matter integrity reveals cognitive computational profiles following COVID-19(OpenEuro, 2026); ; ;MATÍAS IRIARTE CARTER ;VÍCTOR MÁRQUEZMARIA PAZ DE LOS ANGELES MARTINEZ MOLINA - Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - White matter volume and microstructural integrity are associated with fatigue in relapsing multiple sclerosis(GITHUB, 2025) ;FIGUEROA VARGAS, ALEJANDRA; ; ; PAULO CESAR FIGUEROA TAIBA1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Neonatal brain microstructure correlates of neurodevelopment and gait in preterm children 18-22 mo of age: an MRI and DTI study(2015) ;Irene T. Ma ;Suzanne McConaghy ;Kopperuncholan Namachivayam ;Brian A. HalloranAshish R. Kurundkar1Scopus© Citations 47 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 2Scopus© Citations 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection(BMJ, 2025-04) ;Carlos Delfino ;Cheryl Carcel ;Xiaolei Lin; Sharon L Naismith<jats:sec> <jats:title>Introduction</jats:title> <jats:p>Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical activity, mood, health-related quality of life and features of neurovascular impairment and neuroinflammation in adults with ongoing neurological symptoms after COVID-19 infection.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and analysis</jats:title> <jats:p>The STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy study is an ongoing international, investigator-initiated and conducted, multicentre, prospective, randomised, open label, blinded endpoint trial with fixed time points for outcome assessments. A total of 410 participants with long covid neurological symptoms were planned to be randomly assigned to either the intervention group to receive 40 mg atorvastatin for 12 months or to a control group of no treatment, on top of usual care.</jats:p> </jats:sec> <jats:sec> <jats:title>Ethics and dissemination</jats:title> <jats:p>This study protocol was designed, implemented and reported, in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice, the National Health and Medical Research Council of Australia, the National Statement on Ethical Conduct in Human Research and with the ethical principles laid down in the World Medical Association Declaration of Helsinki. Central ethics committee approval was obtained from Sydney Local Health District Royal Prince Alfred Hospital Ethics (No: X21-0113 and 2021/ETH00777 10) in Australia. Site-specific ethics committee approvals were obtained elsewhere before any local study activities. All participants provided written informed consent.</jats:p> </jats:sec> <jats:sec> <jats:title>Trial registration number</jats:title> <jats:p>The study protocol is registered at Clinicaltrials.gov (<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="clintrialgov" xlink:href="NCT04904536">NCT04904536</jats:ext-link>).</jats:p> </jats:sec>3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, White matter volume and microstructural integrity are associated with fatigue in relapsing multiple sclerosis(Springer Science and Business Media LLC, 2025-05-12); ;Sebastián Navarrete-Caro ;Claudia Cárcamo ;Ethel CiampiMacarena Vásquez-Torres10Scopus© Citations 9 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Lateral prefrontal theta oscillations causally drive a computational mechanism underlying conflict expectation and adaptation(2024) ;María Paz Martínez-Molina; ; ;Francisco ZamoranoAntoni Valero-Cabré8Scopus© Citations 15 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Neural Dynamics of Improved Bimodal Attention and Working Memory in Musically Trained Children(2020) ;Leonie Kausel ;Francisco Zamorano; ;Mary E. SutherlandScopus© Citations 13 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Lateral Prefrontal Theta Oscillations Reflect Proactive Cognitive Control Impairment in Males With Attention Deficit Hyperactivity Disorder(2020) ;Francisco Zamorano ;Leonie Kausel ;ALBORNOZ, CARLOS ;Claudio Lavin2Scopus© Citations 21 - Some of the metrics are blocked by yourconsent settings
Item type:Product, Dataset - Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations(OpenNeuro, 2024) ;LEONIE MARGARITA KAUSEL KAMP; ; ; 4
- «
- 1 (current)
- 2
- 3
- »